|
KMID : 1189420190320020068
|
|
Journal of Korean Oriental Medical Ophthalmology & Otolaryngology & Dermatology
2019 Volume.32 No. 2 p.68 ~ p.93
|
|
|
Characteristics of Clinical Trials in Korea for Atopic Dermatitis - Focus on ClinicalTrials.gov Registered Clinical Trials -
|
|
Hwang Mi-Lee
Ahn Jae-Hyun
Jea Ha-Kyung
Kim Soo-Young
Jung Hun-A
|
|
|
Abstract
|
|
|
Objective : This study summarized the characteristics of clinical trials for atopic dermatitis medicines approved by the Ministry of Food and Drug Safety(MFDS). This study may be a reference for the design of clinical trials of atopic dermatitis herbal medicine treatment which may be carried out later.
Method : The characteristics of the clinical trial were analyzed for clinical trials registered with ClinicalTrials.gov, CRIS, and the Korea Health Industry Development Institute among the clinical trial approval statuses posted on the website of the MFDS.
Result : 1. Clinical trial drugs were developed in various formulations such as oral medicines, injections, dermatologic agents, and similar proportions. Relatively little clinical trials were found for herbal medicine.
2. In the control evaluation test, most of the treatments for the control group were performed with placebo using Vehicle.
3. In most clinical trials, one intervention group was in the form of a parallel assignment with only one treatment.
4. The age of the subjects was 11 out of 28 studies including minors, and clinical trials targeting minors were also found to be significant.
5. In the case of atopic dermatitis, the cases of subacute chronic or atopic dermatitis more than 6 months or more than 1 year were often used.
6. Most clinical trials were divided into mild to moderate atopic dermatitis or moderate to severe atopic dermatitis. The SCORAD index, EASI, IGA, BSA, and NRS were used as the evaluation criteria.
7. Regulations for the drugs used prior to the trial period for the treatment of atopic dermatitis vary somewhat from one clinical trial to another.
8. IGA was used most often as a primary efficacy tool, and SCORAD index, EASI, and NRS were also used.
|
|
|
KEYWORD
|
|
|
Atopic Dermatitis, Clinical Trials, MFDS, Drug
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|